LFCR SHAREHOLDER ALERT: ADEMI LLP INVESTIGATES WHETHER BUYOUT FAIRLY VALUES LIFECORE BIOMEDICAL, INC.
PR Newswire•28/09/2026•12:25 ET
0
LFCR SHAREHOLDER ALERT: ADEMI LLP INVESTIGATES WHETHER BUYOUT FAIRLY VALUES LIFECORE BIOMEDICAL, INC. PR Newswire
Lifecore shareholders will receive just $6.28 per share in a transaction valued at up to $663.7 million; Ademi LLP is investigating the deal price, benefits to company insiders, and restrictions on competing offers
Get started
Create a free account to read the full story and Whiz Insights.